RxDoctor Payments Data
★ My doctorsLook up a doctor →

Alexis Voke

Hollywood, FLNPI 1083252126

Payments from drug & device makers

$2,860in general payments, 2019–2025

Across 114 payments — averaging $25.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$340
  • AbbVie$332
  • Boehringer Ingelheim$246
  • Lilly USA, LLC$238
  • AstraZeneca$232
  • GSK$180
  • plus $1K from 18 others

What the payments were for

  • Food & beverage$2,860100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)13$340
AbbVie15$332
Boehringer Ingelheim2$246
Lilly USA, LLC15$238
AstraZeneca13$232
GSK7$180
Viiv Healthcare Company7$168
Exact Sciences4$139
Amgen7$126
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC1$124
E.r. Squibb & Sons, L.L.C.1$117
Antares Pharma, Inc.5$113
Esperion Therapeutics, Inc.5$105
Novartis3$81
Sumitomo Pharma America, Inc.3$67
Pfizer2$43
Axsome Therapeutics, Inc.2$38
Novo Nordisk2$37
Lundbeck LLC1$31
Acella Pharmaceuticals, LLC2$30
Halozyme Inc1$25
Tolmar, Inc.1$17
Kowa Pharmaceuticals America, Inc.1$17
Idorsia Pharmaceuticals US Inc1$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Where these figures come from

Is this you, or does something look wrong? →